1. In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, frequency, and duration of migraines. 2. Patients also valued a lower ...

12–16 Thus, despite the prevalence, cost, morbidity and mortality associated with VTE and PE, prophylaxis and treatment are still in line with CPGs only half the time. This continues to be a problem ...

Most practicing orthopaedic surgeons currently use a pharmacologic agent as a means of prophylaxis for deep venous thrombosis and pulmonary embolism following total hip arthroplasty, total knee ...

Recent studies have indicated a rising incidence of this disease in children over the years. Additionally, the pharmacological treatment of thrombotic diseases in children faces numerous challenges.

A number of risk factors have been associated with venous thromboembolism, such as age, previous history of DVT or PE ... and warfarin are used for pharmacologic prophylaxis.